C Marosi Selected Research

C Marosi Research Topics

Disease

16	Neoplasms (Cancer) 04/2016 - 07/2000
6	Glioblastoma (Glioblastoma Multiforme) 01/2014 - 02/2003
5	Brain Neoplasms (Brain Tumor) 01/2018 - 07/2000
5	Venous Thromboembolism 01/2018 - 12/2009
3	Thrombosis (Thrombus) 02/2016 - 12/2009
2	Glioma (Gliomas) 11/2014 - 08/2001
1	Neoplasm Metastasis (Metastasis) 02/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2012
1	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 04/2010
1	Femoral Neck Fractures 04/2010
1	Weight Loss (Weight Reduction) 09/2008
1	Necrosis 09/2008
1	Chromosomal Instability (Chromosome Stability) 03/2007
1	Brain Edema (Cerebral Edema) 07/2006
1	Hypoxia (Hypoxemia) 12/2004
1	Ependymoma 11/2004
1	Meningioma (Meningiomas) 01/2003
1	Hemorrhage 03/2001
1	Thrombocytopenia (Thrombopenia) 03/2001
1	Breast Neoplasms (Breast Cancer) 03/2001
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2001
1	Pain (Aches) 11/2000
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2000
1	Residual Neoplasm 11/2000
1	Choroid Plexus Papilloma 09/2000

Drug/Important Bio-Agent (IBA)

3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2010 - 11/2004
3	Proteins (Proteins, Gene)FDA Link 07/2008 - 12/2004
2	fibrin fragment D (D-dimer)IBA 02/2016 - 07/2012
2	Temozolomide (Temodar)FDA LinkGeneric 01/2014 - 03/2007
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2003 - 09/2000
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018
1	P-SelectinIBA 04/2016
1	PAR-1 ReceptorIBA 04/2016
1	Proteinase-Activated ReceptorsIBA 04/2016
1	Platelet Membrane Glycoprotein IIbIBA 04/2016
1	Glycoproteins (Glycoprotein)IBA 04/2016
1	SelectinsIBA 02/2016
1	Hemostatics (Antihemorrhagics)IBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 02/2016
1	Thrombin FDA Link 02/2016
1	Factor V (Coagulation Factor V)IBA 01/2015
1	factor V LeidenIBA 01/2015
1	Fluphenazine (Prolixin)FDA LinkGeneric 01/2014
1	Perphenazine (Trilafon)FDA LinkGeneric 01/2014
1	Thromboplastin (Tissue Factor)IBA 07/2012
1	Mesylates (Mesylate)IBA 04/2010
1	Sunitinib (Sutent)FDA Link 04/2010
1	Factor VIII (Coagulation Factor VIII)IBA 12/2009
1	Interleukin-6 (Interleukin 6)IBA 09/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2008
1	CytokinesIBA 09/2008
1	LigandsIBA 07/2008
1	ParaffinIBA 03/2007
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2006
1	Imatinib Mesylate (Gleevec)FDA Link 01/2006
1	AntigensIBA 12/2004
1	Platelet-Derived Growth FactorIBA 11/2004
1	Dacarbazine (DIC)FDA LinkGeneric 02/2003
1	fotemustine (Muphoran)IBA 02/2003
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2003
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2003
1	Interferon-alpha (Interferon Alfa)IBA 01/2003
1	Gemcitabine FDA Link 03/2001
1	Estrogen ReceptorsIBA 09/2000
1	Lomustine (CCNU)FDA Link 09/2000
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 09/2000
1	Androgen Receptors (Androgen Receptor)IBA 09/2000
1	Indicators and Reagents (Reagents)IBA 07/2000
1	RadiopharmaceuticalsIBA 07/2000
1	Dihydrotachysterol (AT 10)IBA 07/2000

Therapy/Procedure

9	Therapeutics 02/2016 - 11/2000
7	Drug Therapy (Chemotherapy) 04/2016 - 11/2000
5	Radiotherapy 04/2010 - 11/2000
1	Terminal Care (Care, Terminal) 11/2014
1	Neck Dissection (Radical Neck Dissection) 04/2010
1	Palliative Care (Palliative Therapy) 04/2010
1	Laminectomy 11/2004
1	Pain Management 11/2000